BRIEF-Relmada Therapeutics Q3 EPS USD -0.12

StubHub Raises Full-Year Gross Merchandise Sales Outlook to $10.3 Billion StubHub raised its full-year gross merchandise sales outlook to $10.3 billion from $10.1 billion. M impact | EARNINGS | Nov 15, 2026, 02:03 AM UTC

Merlin Properties Raises 2026 FFO Guidance to EUR 0.58 per Share Merlin Properties raised its 2026 FFO guidance to EUR 0.58 per share and updated its strategy for its 704 MW data center portfolio. M impact | EARNINGS | Nov 14, 2026, 08:03 PM UTC

Lucara Diamond Raises 2026 Revenue Guidance to USD 140 Million-160 Million Lucara Diamond Raises 2026 Revenue Guidance to USD 140 Million-160 Million Lucara Diamond raised L impact | EARNINGS | Nov 14, 2026, 01:10 AM UTC

Gilead Expects HIV Revenue to Grow About 12% in 2026 Gilead expects HIV revenue to grow about 12% in fiscal 2026. M impact | EARNINGS | Nov 14, 2026, 12:44 AM UTC

Asante Gold Withdraws 2026 Production and Cost Guidance Asante withdrew its 2026 guidance for 275,000–300,000 equivalent ounces at consolidated AISC of $3,200–$3,600/oz after Bibiani underperformed. Nine-month production was 165,594 equ M impact | EARNINGS | Nov 13, 2026, 11:27 PM UTC

Japan's FiEE 9M Revenue More Than Quadruples FiEE's nine-month revenue more than quadrupled, attributed to SaaS expansion. M impact | EARNINGS | Nov 13, 2026, 10:28 PM UTC

BRIEF-Relmada Therapeutics Q3 EPS USD -0.12

Related stories